SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001628280-24-022679
Filing Date
2024-05-10
Accepted
2024-05-10 17:24:52
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 gribioinc-sx3.htm S-3 372098
2 EX-FILING FEES exhibit107-sx3.htm EX-FILING FEES 44614
3 EX-4.4 exhibit44-sx3.htm EX-4.4 356582
4 EX-4.5 exhibit45-sx3.htm EX-4.5 358516
5 EX-5.1 exhibit51-sx3.htm EX-5.1 48289
6 EX-23.1 exhibit231-sx3xmay2024.htm EX-23.1 2612
7 gribiologo1a.jpg GRAPHIC 70146
8 gribiologoa.jpg GRAPHIC 16459
9 mintzlogo.jpg GRAPHIC 256272
  Complete submission text file 0001628280-24-022679.txt   1655837
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037 (619) 400-1171
GRI BIO, Inc. (Filer) CIK: 0001824293 (see all company filings)

IRS No.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-279348 | Film No.: 24936117
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)